Research Compounds

NNMT (nicotinamide N-methyltransferase) inhibitor studied for its effects on adipogenesis, energy expenditure, and NAD+ pathway modulation in metabolic research.

ActRIIB-Fc decoy receptor studied for myostatin and GDF-11 inhibition pathway research. Investigated in muscular dystrophy and sarcopenia preclinical models.

Modified adamantyl-conjugated peptide studied for BDNF-mimetic activity and neuroprotective signaling in models of neuronal survival and cognitive function.

Prohibitin-targeting peptide studied for proapoptotic effects on white adipose tissue vasculature in preclinical obesity research models.

Alanyl-histidyl-lysine copper complex studied for collagen stimulation, hair follicle biology, and dermal remodeling signaling in skin research.

C-terminal fragment of hGH (177–191) studied for lipolytic signaling without IGF-1 axis activation in metabolic and adipogenesis research.

EPO-derived 11-amino acid peptide studied for tissue-protective receptor (TPR) signaling, neuropathy modulation, and anti-inflammatory effects in preclinical models.

Body Protection Compound studied extensively in gastric and musculoskeletal research models for its effects on growth factor expression and tissue signaling pathways.

Triple-compound research blend combining BPC-157, GHK-Cu, and TB-500 for comprehensive tissue healing, collagen synthesis, and regeneration pathway research.

Combined BPC-157 and TB-500 (Thymosin Beta-4) blend for synergistic tissue repair signaling research. Both compounds studied in healing and recovery models.

Long-acting amylin analogue studied for satiety signaling, gastric emptying, and glucagon suppression in metabolic and obesity research models.

GHRH analogue with Drug Affinity Complex studied for prolonged GH secretion effects and extended half-life characteristics in research models.

Modified GHRH fragment studied for its shorter-acting pulsatile GH-releasing activity in cell and animal models.

Classic GHRH + GHRP combination studied for synergistic pulsatile GH secretion, somatotroph axis stimulation, and body composition pathway research.

Endogenous neuropeptide studied for its role in sleep cycle modulation, stress response regulation, and neuroendocrine signaling in sleep research models.

Synthetic tetrapeptide derived from the pineal gland studied for telomerase activation, circadian rhythm regulation, and antioxidant effects in aging research models.

Activin-binding glycoprotein studied for myostatin inhibition, FSH suppression, and muscle fiber hypertrophy signaling in musculoskeletal research.

D-retro-inverso FOXO4 peptide studied for selective senescent cell apoptosis induction (senolysis) in aging and lifespan extension research models.

Naturally occurring copper-binding tripeptide studied for collagen synthesis stimulation, wound healing signaling, and antioxidant gene expression in research models.

Second-generation growth hormone releasing peptide studied for potent GH secretagogue activity with minimal cortisol/prolactin effects in research models.

Growth hormone releasing hexapeptide studied for its ghrelin receptor agonist activity and GH secretion effects in preclinical research.

Studied in metabolic and endocrinology research for its interaction with incretin and energy-balance pathways in cell and animal models.

Dual compound research blend combining GLP-1 (Semaglutide) and Cagrilintide for synergistic incretin + amylin pathway research in metabolic models.

Dual GIP/GLP-1 receptor agonist studied extensively in metabolic research for energy regulation and body composition pathways.

Triple GIP/GLP-1/Glucagon receptor agonist investigated in advanced metabolic research models for its multi-receptor activity.

Triple/amylin receptor combination blend studying synergistic Retatrutide + Cagrilintide multi-pathway activity in advanced metabolic research models.

Master antioxidant tripeptide studied for oxidative stress reduction, detoxification pathway support, and immune cell function modulation in cell biology research.

Glycoprotein hormone studied for LH receptor activation, Leydig cell steroidogenesis stimulation, and follicular development research in reproductive biology.

Potent synthetic GHRP studied for GH secretagogue activity and cardiac receptor binding properties in preclinical models.

Recombinant human growth hormone (191 amino acid sequence) studied for GH receptor binding, IGF-1 axis activation, and anabolic pathway research.

FSH/LH gonadotropin blend studied for follicular stimulation, spermatogenesis, and steroidogenesis pathway research in reproductive biology models.

Long R3 IGF-1 analogue with extended half-life studied for its anabolic signaling, myogenesis, and protein synthesis pathway effects in research models.

Selective growth hormone secretagogue studied for its GH-releasing effects with high receptor selectivity in in-vitro and animal research models.

Synthetic GnRH analogue studied for pulsatile LH/FSH release stimulation and HPG axis regulation in reproductive endocrinology research.

Comprehensive four-compound research blend combining BPC-157, GHK-Cu, TB-500, and KPV for multi-pathway tissue repair and anti-inflammatory research.

C-terminal alpha-MSH tripeptide studied for anti-inflammatory cytokine modulation and mucosal healing properties in cell culture research.

Lipolytic blend containing riboflavin and plant-derived compounds studied for localized adipocyte disruption signaling in aesthetic and metabolic research.

Lipotropic B-complex blend studied for fat metabolism enhancement and hepatic lipid processing in metabolic research. Contains MIC + B12.

Extended lipotropic blend with added carnitine studied for enhanced fatty acid transport and cellular energy metabolism research applications.

Human cathelicidin antimicrobial peptide studied for immune modulation, angiogenesis promotion, and wound healing facilitation in preclinical models.

GLP-1/GCG dual receptor agonist studied in metabolic research for its combined energy expenditure and appetite regulation pathway activity.

Cyclic lactam analogue of alpha-MSH studied for melanocortin receptor binding, melanogenesis pathway activation, and pigmentation research.

IGF-1 splice variant studied for its role in satellite cell activation and muscle fiber repair signaling in mechanical stress research models.

Oral ghrelin mimetic studied for sustained GH/IGF-1 axis stimulation, sleep architecture effects, and nitrogen retention in research models.

Mitochondrial-derived peptide studied for its role in metabolic regulation, insulin sensitivity pathways, and cellular energy homeostasis.

Linear alpha-MSH analogue studied for MC1R agonism, melanogenesis pathway activation, and UV photoprotection signaling in dermatology research.

Enhanced acetylated/amidated form of Epithalon studied for improved stability and bioavailability in telomerase activation and anti-aging research.

Nicotinamide adenine dinucleotide studied for mitochondrial function, sirtuin pathway activation, DNA repair, and cellular energy metabolism in aging research.

Nonapeptide neurohormone studied for social bonding neuroscience, HPA axis modulation, uterine contractility, and lactation pathway research.

Synthetic peptide studied for synaptogenesis promotion and neurotrophic activity in models of neurodegeneration and cognitive decline.

SPAR peptide studied for synaptamide pathway modulation, neuroplasticity, and antidepressant-like effects in hippocampal cell research models.

Tripeptide (Ala-Glu-Asp) derived from the pineal gland studied for cerebral blood flow, circadian regulation, and neuroprotective effects in aging research.

Melanocortin receptor agonist studied for its central nervous system–mediated effects on sexual arousal pathways in neuropharmacology research.

Synthetic analogue of tuftsin studied for anxiolytic, nootropic, and immunomodulatory effects on GABA and serotonin pathways in preclinical models.

Neuropeptide mixture derived from porcine brain tissue studied for neurotrophic factor mimicry and neuroprotective effects in cognitive research models.

Synthetic GHRH analogue (first 29 amino acids) studied for natural pulsatile GH secretion effects in hypothalamic-pituitary axis research.

ERR (estrogen-related receptor) agonist studied for mitochondrial biogenesis, exercise mimicry, and metabolic pathway activation in longevity and fitness research.

Octapeptide studied for SNAP-25 protein competition and acetylcholine release modulation in neuromuscular junction and wrinkle formation research.

Mitochondria-targeted peptide studied for oxidative stress reduction, mitochondrial membrane protection, and cardioprotective signaling in aging and metabolic research.

Dual GLP-1/Glucagon receptor agonist studied for energy expenditure, fat oxidation, and metabolic homeostasis pathway modulation in preclinical research.

Thymic peptide researched for its role in actin regulation, cell migration, angiogenesis, and wound healing signaling in preclinical models.

Synthetic GHRH analogue studied for visceral adipose reduction, GH/IGF-1 axis stimulation, and body composition effects in metabolic research.

Tetrapeptide (Lys-Asp-Glu-Gly) studied for testicular peptide-like activity, Leydig cell function, and testosterone pathway regulation in aging and endocrine research.

Thymus-derived peptide studied for immune restoration, T-cell regulation, and neuroendocrine modulation in aging and immunodeficiency research models.

Dipeptide (Lys-Glu) studied for thymic peptide-like activity, immune restoration, and vascular endothelium function modulation in aging research models.

28-amino acid neuropeptide studied for vasodilatory, anti-inflammatory, bronchodilatory, and immunomodulatory signaling in a wide range of research models.

Methylcobalamin form of B12 studied for methylation pathway support, neurological function, homocysteine regulation, and energy metabolism research.